Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry
Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, DeAngelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLOS ONE 2013, 8: e67306. PMID: 23825651, PMCID: PMC3688991, DOI: 10.1371/journal.pone.0067306.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCell Line, TumorHeterograftsHumansImmunohistochemistryMiceMutationReceptor, Notch1ConceptsCell lymphomaNotch1 activationNOTCH1 mutationsPeripheral T-cell lymphomaNon-small cell lung carcinomaLymphoblastic leukemia/lymphomaTriple-negative breast cancerLarge B-cell lymphomaSelection of patientsChronic lymphocytic leukemia cellsT-cell lymphomaCell lung carcinomaNegative breast cancerChronic lymphocytic leukemiaLeukemia/lymphomaB-cell lymphomaMantle cell lymphomaB-cell tumorsRole of Notch1Lymphocytic leukemia cellsLymph nodesAngioimmunoblastic lymphomaCell tumorsClinical trialsOvarian carcinoma